Brief New Treatment for Suicide Attempts
NCT03300596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2020-09-17
Summary
Individuals with alcohol or drug use problems who are hospitalized for suicide attempt are at high risk for reattempt. This treatment development study adapts a promising outpatient intervention to prevent suicide reattempt in order to administer it during hospitalization to individuals with alcohol and drug use problems, and to test the adapted intervention in a pilot randomized controlled trial.
Conditions
- Suicide, Attempted
- Drug Use
- Alcohol; Use, Problem
Interventions
- BEHAVIORAL
-
Brief intervention to prevent suicide attempt
A patient-centered, 3-session intervention that calls for videotaping the narrative story of a patient's suicide attempt, in his/her own words (session 1); reviewing segments of the tape to arrive at a shared understanding of the attempt and the sequence of events that led to it (session 2); and using this information, along with a homework task completed by the patient in-between sessions, in order to develop a collaborative, comprehensive written safety plan that addresses the patient's unique vulnerabilities (session 3).
- BEHAVIORAL
-
Enhanced treatment as usual
Safety procedures' control intervention. For these procedures we will share summary results of the research assessments regarding suicidal thoughts, suicidal behaviors, alcohol and drug use and related problems, and depressive symptoms with appropriate hospital clinical staff. We will also arrange to send this information, with participants' permission, to their ongoing therapist or treatment program and, if none exists, to the therapist or program to which they are being referred. In this regard, the research assessment protocol serves a dual function of helping with additional monitoring of high-risk patients in addition to providing data for the study.
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
collaborator NIH -
University of Rochester
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-12
- Primary Completion
- 2020-09-15
- Completion
- 2020-09-15
Countries
- United States
Study Locations
More Related Trials
-
Reducing Alcohol Use in Depressed Patients
NCT00183079 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder
NCT06648655 ·Status: TERMINATED ·Phase: PHASE2
-
PT150 Drug for Use in Alcohol Use Disorder
NCT06712602 ·Status: RECRUITING ·Phase: PHASE1
-
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
NCT00453804 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Determination Of The Clinical Utility Of Perampanel For The Treatment Of Alcohol Dependence
NCT02120365 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking
NCT04084860 ·Status: RECRUITING ·Phase: PHASE2
-
Apremilast for Alcohol Use Disorder Treatment in Women and Men
NCT06324435 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Sex Differences in the Response to Abstinence From Alcohol.
NCT03827460 ·Status: RECRUITING ·Phase: PHASE1
-
Self-Injury: Diagnosis and Treatment
NCT00065936 ·Status: UNKNOWN ·Phase: PHASE3
-
Naltrexone Treatment for Alcoholic Women
NCT00000448 ·Status: COMPLETED ·Phase: PHASE4
-
Soberlink Within In-Home Addiction Treatment Program
NCT03902171 ·Status: UNKNOWN
-
Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
NCT03539887 ·Status: COMPLETED ·Phase: PHASE3
-
Targeted Naltrexone for Problem Drinkers
NCT00369408 ·Status: COMPLETED ·Phase: PHASE4
-
Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
NCT00449007 ·Status: TERMINATED ·Phase: PHASE4
-
Trazodone for Sleep Disturbance in Early Alcohol Recovery
NCT00027053 ·Status: COMPLETED ·Phase: PHASE2
-
Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal
NCT04159909 ·Status: WITHDRAWN ·Phase: NA
-
Facilitating Use of the National Suicide Prevention Lifeline in Alcohol Patients (Reach Out)
NCT04488055 ·Status: COMPLETED ·Phase: NA
-
Zonisamide vs. Placebo in the Treatment of Alcohol Dependence
NCT00595556 ·Status: COMPLETED ·Phase: PHASE4
-
Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)
NCT03575403 ·Status: COMPLETED ·Phase: PHASE1
-
An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
NCT05674929 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome
NCT03818191 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels
NCT05487404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study
NCT00769158 ·Status: COMPLETED ·Phase: PHASE1
-
Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT05223829 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Ketamine for the Treatment for Alcohol Use Disorder in the ED
NCT05661669 ·Status: WITHDRAWN ·Phase: PHASE2